Medtronic (NYSE:MDT) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Medtronic (NYSE:MDT) had its price target lowered by analysts at JPMorgan Chase & Co. from $105.00 to $100.00. They now have a "neutral" rating on the stock.
Medtronic (NYSE:MDT) had its price target lowered by analysts at Leerink Partners from $120.00 to $119.00. They now have an "outperform" rating on the stock.
Medtronic (NYSE:MDT) had its price target lowered by analysts at Needham & Company LLC from $121.00 to $120.00. They now have a "buy" rating on the stock.
Medtronic (NYSE:MDT) had its price target lowered by analysts at Robert W. Baird from $103.00 to $100.00. They now have a "neutral" rating on the stock.